Plasmapheresis for prevention and regression of coronary atherosclerosis.
Yamamoto
A
A
National Cardiovascular Center, Research Institute, Osaka-fu, Japan.
Kojima
S
S
Harada-Shiba
M
M
Toyota
Y
Y
Takamiya
M
M
Tsushima
M
M
Kishino
B
B
Koga
N
N
Tatami
R
R
D000293:Adolescent; D000328:Adult; D001161:Arteriosclerosis / Q000517:prevention & control* / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D003324:Coronary Artery Disease / Q000517:prevention & control* / Q000628:therapy; D005260:Female; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D006937:Hypercholesterolemia / Q000628:therapy*; D006938:Hyperlipoproteinemia Type II / Q000628:therapy*; D008077:Lipoproteins, LDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis / Q000379:methods*
D008077:Lipoproteins, LDL